|
July 17, 2026 — FxNutrition Intelligence
Evidence-driven intelligence for functional nutrition practitioners
A Nutrishify publication • Week of July 17, 2026
|
|
Hello!
New: refer one colleague, get the Prompt Pack.
You know the colleague I mean — the one who pours everything into their clients and has nothing left over for keeping up with the research, the podcasts, and the trainings. Send them the brief.
They get one friendly invitation from me (no auto-subscribe — they decide for themselves). You get The Functional Nutrition Practitioner’s AI Prompt Pack: 15 field-tested prompts for client feedback, lab-pattern brainstorming, meal planning, and practice building.
Takes 30 seconds: Refer a colleague →
|
|
Evidence Spotlight
|
Sarcopenia & Cancer Outcomes
An umbrella meta-analysis pooling findings from 59 existing meta-analyses across 12 cancer types found that sarcopenia — low skeletal muscle mass assessed by imaging — consistently predicts worse treatment outcomes regardless of cancer type or treatment approach. In surgical patients, sarcopenic individuals had roughly 59% higher risk of shorter overall survival and 64% higher risk of shorter disease-free survival compared to those with adequate muscle mass; postoperative complication rates were also elevated. The same pattern held in non-surgical first-line therapy and immunotherapy, where sarcopenia independently predicted poorer survival — suggesting this is a robust signal, not a finding limited to any single cancer or treatment context.
Takeaway: Muscle mass is emerging as a meaningful prognostic variable in oncology — not just a wellness metric. For nutrition practitioners working with cancer patients or oncology-adjacent clients, this evidence strengthens the case for prioritizing muscle preservation through protein adequacy and resistance training as part of any supportive care conversation.
|
Vitamin D & Early Pregnancy Bleeding
A secondary analysis of the EAGeR randomized controlled trial (n=747) — a multisite study enrolling women with one or two prior pregnancy losses — found that persistently low vitamin D (25(OH)D) from preconception through 8 weeks of gestation was associated with more than double the odds of subchorionic hemorrhage and roughly triple the odds of moderate-to-heavy vaginal bleeding, compared to women with sufficient levels at both time points. The association was specific to more severe bleeding; light bleeding showed no significant link to vitamin D status. Findings held in a population already at elevated pregnancy risk, and the authors point to vitamin D’s role in implantation and early placental development — not only fetal bone formation — as a plausible mechanism.
Takeaway: This study gives preconception practitioners a concrete optimization target: achieving and maintaining vitamin D sufficiency at ≥30 ng/mL before conception and through the first trimester, particularly for clients with a history of pregnancy loss, may be worth prioritizing in preconception protocols.
|
Glucose Ketone Index as a Metabolic Biomarker
This systematic review and proposal introduces the glucose ketone index (GKI) — the ratio of blood glucose to β-hydroxybutyrate — as a point-of-care biomarker for assessing metabolic health in the context of chronic disease prevention and management. Originally developed for monitoring dietary adherence in cancer therapy, the authors argue GKI captures metabolic state more completely than glucose alone: lower ratios are associated with reduced systemic inflammation, better insulin sensitivity, and lower activation of pathways linked to tumor growth. Because both values can be measured with standard home meters, GKI offers an accessible, individualized monitoring tool that nutrition practitioners can incorporate alongside dietary and exercise interventions.
Takeaway: For practitioners working in metabolic health or oncology-adjacent nutrition, GKI represents an early-signal framework worth tracking — it may offer a more complete picture of a client’s metabolic state than fasting glucose or ketones measured in isolation, particularly when monitoring adherence to low-carbohydrate or ketogenic dietary approaches.
|
|
By The Numbers
59 meta-analyses
All pointing the same direction: sarcopenia predicts worse cancer outcomes across 12 tumor types and every major treatment modality.
This umbrella meta-analysis pooled findings from 59 existing meta-analyses covering surgical patients, first-line non-surgical therapy, and immunotherapy. The signal was consistent: sarcopenic cancer patients faced roughly 59% higher mortality risk after surgery (HR=1.59) and 49% higher risk in non-surgical settings (HR=1.49). Muscle mass isn’t just a wellness metric — it’s a prognostic variable that’s modifiable with targeted nutrition and resistance training.
|
|
|
Clinical Pearl
Low vitamin D before conception triples early pregnancy bleeding risk
Women who remained vitamin D deficient or insufficient from preconception through 8 weeks of pregnancy had a 3-fold increased odds of moderate-to-heavy vaginal bleeding (aOR=3.02) and more than double the odds of subchorionic hemorrhage (aOR=2.18), compared to women with sufficient levels at both timepoints.
The findings point to vitamin D’s role in early placentation and implantation — not just fetal bone development. The study used a sufficiency threshold of ≥30 ng/mL, providing a concrete preconception optimization target.
|
|
|
|
Recent Podcasts
|
Fracture-Proof Your Future – Bone Health with Dr. John Neustadt
The Lab Report • July 14, 2026
A deeper framework for bone health beyond calcium and vitamin D. Dr. John Neustadt discusses how to use functional lab data to assess fracture risk before it becomes clinical — covering nutrition, lifestyle, and skeletal resilience across the lifespan. Useful if you work with perimenopausal, postmenopausal, or aging clients and want a stronger foundation for translating bone-health labs into practice conversations. Listen →
|
Food, Mold, Ticks, and the Immune System with Alletess Medical Laboratory
The Root Cause Medicine Podcast • July 10, 2026
Worth a listen if you encounter clients with multifactorial immune or inflammatory patterns that don’t resolve cleanly with standard dietary interventions. Clinicians from Alletess Medical Laboratory address how food sensitivities, mold exposure, and tick-borne illness interact and compound — and how testing can help distinguish between overlapping presentations. Listen →
|
The New Frontier of Dementia Prevention
Brain Health Kitchen • July 10, 2026
A resource for practitioners refining how they discuss cognitive aging and prevention-oriented lab work with midlife clients. The conversation spans cardiovascular contributors such as apolipoprotein B (ApoB) and lipoprotein(a) (Lp(a)), genetic risk factors including APOE4, homocysteine, and newer blood-based markers such as phosphorylated tau 217 (p-tau 217) — with a focus on upstream identification and modifiable risk. Listen →
|
The Microbiome Connection: Optimizing Health from the Inside Out
BetterHealthGuy Podcast • June 21, 2026
A strong listen for practitioners who want to deepen their clinical microbiome knowledge beyond basic probiotic recommendations. Jason Hawrelak, ND, PhD — a leading microbiome researcher and clinician — covers how microbiome composition connects to immune function, inflammation, and overall resilience, drawing on clinical research throughout. Listen →
|
Genomic Testing for Post-Menopausal Care
CNS Unfiltered: Journal Club • 2026 Q2
Valuable if you work with post-menopausal clients and want to understand where genomic data adds clinical signal beyond standard labs. This Journal Club format unpacks the clinical application of genomic testing in post-menopausal care, examining how genetic data can inform nutrition and hormone-health strategies — and bridging the gap between research and practice for clinicians curious about precision nutrition. Listen →
|
|
Mark Your Calendar
|
July 23
Detoxification Starts at the Membrane: The Origin and Science Behind a 30-Year Clinical Protocol
Live webinar • BodyBio HCP / Dr. Kara Fitzgerald • 12:00 ET — Register →
|
July 29
Identifying & Addressing Low Androgens in Midlife
Live webinar • DUTCH Test • 12:00 PT — Register →
|
July 29
Getting Started with GI Testing: Selecting the Right Patient and the Right Kit
Live webinar • Kalish Institute + Fullscript • 12:00 PT / 3:00 ET — Register →
|
August 11
Reversing Years of Complex Unexplained Symptoms in 6 Months
Live webinar • Genova Diagnostics • 7:00 ET / 12:00 BST — Register →
|
September 16
Discussion with the article authors — Glucose Ketone Index and Metabolic Health
Live author discussion • Frontiers in Science • 16:00 CEST — features the researchers behind this week’s GKI Evidence Spotlight. Register →
|
|
Org/Industry Updates
|
ANA Members: New Discount on Examine+
The American Nutrition Association (ANA) has partnered with Examine.com to offer members up to 34% off Examine+ and the Examine Clinician Edition — both research-synthesis tools widely used in functional and integrative nutrition practice, each including a 7-day free trial and 60-day money-back guarantee. If you’re an ANA member, the discount can be claimed through your membership benefits page or the ANA newsletter. Disclosure: the link below is a referral link. Learn more →
|
|
Tech Tip
|
The One Prompt to Run on Everything Else
Whatever AI output you’re working with this week — a client handout, a lab-pattern brainstorm, a fact sheet — run this as a second pass before you use it:
“Review your previous response as a skeptical clinical reviewer. Identify: (1) any claim that’s overstated relative to evidence, (2) anything a licensed practitioner would flag as outside nutrition scope of practice, (3) any number, dose, or citation I should verify before using. Be harsh.”
The practitioners who get the most out of AI aren’t the best prompters — they’re the best editors. This prompt makes that editing pass automatic instead of optional.
This one’s from The Functional Nutrition Practitioner’s AI Prompt Pack — 15 more like it, free when you refer a colleague. Refer a colleague →
|
|
© 2026 Nutrishify · Questions or feedback? Email hello@nutrishify.com
|